Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
6.72
+0.13 (1.97%)
At close: Mar 13, 2026, 4:00 PM EDT
6.90
+0.18 (2.68%)
After-hours: Mar 13, 2026, 7:13 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $703.13 million as of March 13, 2026. Its market cap has increased by 87.88% in one year.
Market Cap
703.13M
Enterprise Value
507.19M
1-Year Change
87.88%
Ranking
Category
Stock Price
$6.72
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $703.13M, a decrease of -17.05%. That is a compound annual growth rate of -2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 703.13M | -0.53% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.55B |
| GeneDx Holdings | 2.28B |
| GRAIL | 1.77B |
| NeoGenomics | 1.02B |
| OPKO Health | 913.56M |
| CareDx | 871.19M |
| Castle Biosciences | 759.93M |
| Fulgent Genetics | 461.28M |